HHI-EMD targets oxicat prototype test by Q3 2024


Source: HHI-EMD

Hyundai Heavy Industries Engine & Machinery Division (HHI-EMD) held a webinar on 30 October 2023 discussing its after-treatment research for LNG, and announced that it plans to complete the prototype of its methane oxidation catalyst (oxicat) technology by Q3 2024.

Speaking at the webinar, senior engineer Yoonyong Kim noted that the Methane Oxidation Catalyst System (MOCS) formed part of the company’s efforts to reduce methane slip from its dual-fuel 4-stroke engines..

Kim noted that HiMSEN had retained a market leading position in the dual-fuel LNG newbuilding segment, where the proportion of orders received by HHI-EMD reached 66% in 2022, in a market where over 100 LNGC newbuildings were ordered. HHI-EMD had achieved market shares of 78% in 2020 and 2021, albeit in markets with lower ordering activity.

Kim clarified that the revised product development schedule will see a prototype test occur in Q3 2024. 

Continue this article…

Already subscribed? SIGN IN now


Sign up for FREE to continue this article!

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy:

  • Weekly newsletters providing valuable news and information on the shipping sector
  • Full access to our news archive
  • Live and archived webinars, podcasts and videos
  • Articles on innovations and current trends in the shipping industry
  • Our extensive archive of data, research and intelligence

Get more free content sign up today

Ready to subscribe? Choose from one of our subscription packages for unlimited access!